Holen Sie sich die Stockscreener-App
0.3229
4.69%
-0.0159
Vorhandelsmarkt:
.29
-0.0329
-10.19%
Lunai Bioworks Inc Aktie (LNAI) Neueste Nachrichten
Lunai Bioworks signs letter of intent with Geneial for rare disease data collaboration - Investing.com Australia
What's Behind The Jump In Lunai Bioworks Stock? - MSN
Lunai's rare disease data pact aims to build trial-ready patient groups - Stock Titan
Lunai Bioworks unit secures defense collaboration for AI chemical threat platform - MSN
Lunai Bioworks completes $20M transaction to acquire BBB - MSN
Reverse split range 1-for-3 to 1-for-30 proposed by Lunai Bioworks (NASDAQ: LNAI) - Stock Titan
Lunai Bioworks (LNAI) seeks approval for wide-range reverse stock split to support Nasdaq listing - Stock Titan
LNAI Stock Chart | LUNAI BIOWORKS INC (NASDAQ:LNAI) - ChartMill
Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion - Sahm
Lunai Bioworks (LNAI) Stock: New Defence Collaboration Unlocks Revenue and Innovation - parameter.io
Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M - MSN
Lunai Bioworks (NASDAQ: LNAI) asks shareholders to approve up to 1‑for‑30 reverse split - Stock Titan
Lunai Bioworks Inc (2Q50.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Lunai Bioworks Inc Com (LNAI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Lunai Bioworks Expands CNS Portfolio With $20M Acquisition - TipRanks
Lunai Bioworks Unveils $20M Preferred Investment and Debt-for-Equity Exchange to Advance CNS Assets - TradingView — Track All Markets
Lunai Bioworks (NASDAQ: LNAI) secures $20M CNS Alzheimer’s deal and converts secured debt - Stock Titan
Lunai Bioworks acquires CNS drug delivery tech for $20M By Investing.com - Investing.com Australia
Why did LNAI stock skyrocket over 130% pre-market today? - MSN
Microcap March Madness: LNAI, FAGI, VSA, LNKS Sweet 16 Underdog Watch - Barchart.com
Lunai Bioworks Acquires $20M in BBB Delivery Tech, CNS Alzheimer’s Assets from Clemann Group - Contract Pharma
Why did LNAI stock skyrocket over 130% pre-market today? | Tap to know more | Inshorts - Inshorts
Lunai Bioworks, Inc. (LNAI) Stock: No-Reset Convertible Deal Boosts CNS Drug Development Edge - parameter.io
Lunai Bioworks (LNAI) Acquires BBB Technology in $20M Deal - GuruFocus
Why Did LNAI Stock Surge Over 25% Today? - Stocktwits
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications - Finviz
LNAI Enhances CNS Pipeline with Strategic Acquisition - GuruFocus
Why Did LNAI Stock Skyrocket Over 130% Pre-Market Today? - stocktwits.com
Lunai Bioworks acquires CNS drug delivery tech for $20M - Investing.com
Lunai Bioworks Executes $20M Strategic Transaction At Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform For Cns Alzheimer's Therapies With Broad Cns Delivery Applications - TradingView
Lunai Bioworks Inc. has executed binding agreement to acquire BBB delivery technology and CNS Alzheimer's drug assets of Clemann Group from Clemann Group for $20 million. - marketscreener.com
If You Invested $1,000 in Renovaro (RENB) - Stock Titan
$400M to $1.2 Billion US Countermeasures Program Presents Huge Opportunity for New AI Platform to Meet Emerging Battlefield and Terrorism Threats: Lunai Bioworks (Nasdaq: LNAI) - Barchart.com
$400M to $1.2 Billion US Countermeasures Program Presents Huge - openPR.com
Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI) - PRLog
Lunai Bioworks Engages Initial U.S. Countermeasure Opportunities Following $400M–$1.2B Consortium Launch - weeklyvoice.com
Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model - Finviz
LNAI Initiates Consortium to Speed Up Chemical Countermeasure De - GuruFocus
Lunai Bioworks (LNAI) Stock Forecast and Price Target 2026 $LNAI - MarketBeat
LNAI stock: Lunai Bioworks (NASDAQ) $0.52, vol 509,735,274 on 17 Mar 2026: monitor AI oncology signals - Meyka
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):